Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Nexalin Technology, Inc. - Warrant (NQ:NXLIW)

0.0138 UNCHANGED

Last Price Updated: 3:18 PM EDT, Sep 19, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	0.0138
Bid (Size)	0.0103 (40)
Ask (Size)	0.0179 (184)
Prev. Close	0.0138
Today's Range	0.0138 - 0.0138
52wk Range	0.0080 - 0.7400
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4

December 02, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin’s 15 Milliamp Neurostimulation Device Demonstrates Promising Results in Treating Gambling Disorder with Alcohol Use Comorbidity

November 18, 2025

Peer-reviewed case report published in The American Journal on Addictions highlights significant clinical improvement and sustained abstinence following Nexalin’s non-invasive therapy

From Nexalin Technology, Inc.

Via GlobeNewswire

Performance

YTD	-96.7%	-96.7%
1 Month	N/A	N/A
3 Month	-69.4%	-69.4%
6 Month	-91.3%	-91.3%
1 Year	-97.7%	-97.7%

More News

Nexalin Technology Appoints Carmi Masha Technologies Ltd. as Exclusive Distributor in Israel

November 13, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia

November 05, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Announces Regulatory Approval to Sell Gen 2 SYNC, 15 mA Neurostimulation DIFS™ Device in Israel

October 30, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin’s DIFS™ Neurostimulation Shows Cognitive and Brain Network Improvements in Alzheimer’s and Dementia Across Three Peer-Reviewed Studies

October 21, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Expands Scientific Advisory Board with Appointment of Dr. Robert Rothstein to Support Alzheimer’s and Traumatic Brain Injury Programs

October 13, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Announces Attendance at the 2025 Maxim Growth Summit

October 10, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer’s Disease with Gen-2 SYNC Neurostimulation Device

October 08, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Announces Issuance of U.S. Patent Covering HALO™ Clarity Device Featuring DIFS™ Technology

September 25, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on September 9

August 25, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin’s Next Phase of Growth and Strategic Initiatives

August 01, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on June 3

May 28, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging Data

May 13, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback

May 01, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia

April 24, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Announces Completion of Phases One Through Five of its Virtual Clinic and Digital Ecosystem for HALO™ Clinical Research and Patient Management

April 23, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Expresses Strong Support for Health Tech Investment Act to Advance Medicare Reimbursement for AI-Enabled Devices

April 21, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders

April 14, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial

April 02, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on April 3

March 26, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders

March 03, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval

February 28, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board

February 26, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment

February 18, 2025

From Nexalin Technology, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Nexalin Technology, Inc. - Warrant publicly traded?

Yes, Nexalin Technology, Inc. - Warrant is publicly traded.

What exchange does Nexalin Technology, Inc. - Warrant trade on?

Nexalin Technology, Inc. - Warrant trades on the Nasdaq Stock Market

What is the ticker symbol for Nexalin Technology, Inc. - Warrant?

The ticker symbol for Nexalin Technology, Inc. - Warrant is NXLIW on the Nasdaq Stock Market

What is the current price of Nexalin Technology, Inc. - Warrant?

The current price of Nexalin Technology, Inc. - Warrant is 0.0138

When was Nexalin Technology, Inc. - Warrant last traded?

The last trade of Nexalin Technology, Inc. - Warrant was at 09/19/25 03:18 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.